Document is current
Any future updates will be listed below
-
Authors
Savides, Michael T.
Bhatia, Harpreet S.
Kuznetsova, Inna
Wilkinson, Michael J.
- License Information
-
More Information
Article History
Received: 23 March 2026
Accepted: 23 June 2026
First Online: 10 July 2026
Declarations
:
: N/A.
: Funding: HSB and MJW are supported by the BEACON Lp(a) Research Center at UC San Diego. HSB is supported by National Institutes of Health, Grant 1K08HL166962. MJW is supported by the National Institutes of Health grants 1R01DK118278-01 and R01DK139356 and by a grant from the Larry L. Hillblom Foundation. The content of this article is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.Conflict of Interest: HSB is a consultant / advisor for Kaneka, Novartis, Arrowhead, Merck, Bayer, Abbott and NewAmsterdam. MJW is a consultant to Amarin, Regeneron, Kaneka, Ionis, and NewAmsterdam; reports advisory board fees from Lilly, Novartis, Regeneron, Ionis, Arrowhead, and NewAmsterdam; received grant support from Amgen and Esperion (investigator-initiated studies) and support through an institutional consulting agreement with Novartis paid to his institution for advising on research; and has contracted research grants to his institution with Amgen, Novartis, Ionis, Lilly, Silence, and Mineralys. MTS and IK have no relevant disclosures.
